135 related articles for article (PubMed ID: 3028922)
21. Kappa-opiates and urination: pharmacological evidence for an endogenous role of the kappa-opiate receptor in fluid and electrolyte balance.
Huidobro-Toro JP; Parada S
Eur J Pharmacol; 1984 Dec; 107(1):1-10. PubMed ID: 6098480
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of diuretic action of spiradoline (U-62066E)--a kappa opioid receptor agonist in the human.
Rimoy GH; Bhaskar NK; Wright DM; Rubin PC
Br J Clin Pharmacol; 1991 Nov; 32(5):611-5. PubMed ID: 1659438
[TBL] [Abstract][Full Text] [Related]
23. Mr 2033 CL--a novel non-morphine-like opioid analgesic.
Stockhaus K; Ensinger HA; Gaida W; Jennewein HM; Merz H
NIDA Res Monogr; 1983 Apr; 43():144-9. PubMed ID: 6135993
[TBL] [Abstract][Full Text] [Related]
24. Dynorphin A1-13 stimulates ovine fetal pituitary-adrenal function through a novel nonopioid mechanism.
Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
J Pharmacol Exp Ther; 1997 Jan; 280(1):416-21. PubMed ID: 8996223
[TBL] [Abstract][Full Text] [Related]
25. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
26. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
27. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
[TBL] [Abstract][Full Text] [Related]
28. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
Negus SS; Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
[TBL] [Abstract][Full Text] [Related]
29. The effects of the selective kappa-opioid agonist MR 2034 on the guinea-pig ileum.
Coupar JM; Quinn MJ
J Pharm Pharmacol; 1988 May; 40(5):378-80. PubMed ID: 2899640
[TBL] [Abstract][Full Text] [Related]
30. Opiate receptor subtypes in the regulation of thyrotropin and prolactin secretion in the rat.
Rauhala P; Tuominen RK; Männistö PT
Horm Res; 1988; 29(5-6):218-22. PubMed ID: 2851523
[TBL] [Abstract][Full Text] [Related]
31. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
Panerai AE; Martini A; Sacerdote P; Mantegazza P
Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
[TBL] [Abstract][Full Text] [Related]
32. Delineation of mu-antagonist, partial kappa agonist and non-opioid agonist activity of cyclazocine using urinary output of rats.
Leander JD
Pharmacol Biochem Behav; 1987 Apr; 26(4):705-7. PubMed ID: 3037567
[TBL] [Abstract][Full Text] [Related]
33. Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist.
Fuller RW; Leander JD
J Pharm Pharmacol; 1984 May; 36(5):345-6. PubMed ID: 6145778
[TBL] [Abstract][Full Text] [Related]
34. N-tetrahydrofurfuryl benzomorphans: comparison of a kappa and an agonist/antagonist analgesic.
Wood PL
Neuropeptides; 1985 Feb; 5(4-6):323-6. PubMed ID: 2987733
[TBL] [Abstract][Full Text] [Related]
35. Opiate control of spontaneous locomotor activity in a urodele amphibian.
Deviche P; Lowry CA; Moore FL
Pharmacol Biochem Behav; 1989 Dec; 34(4):753-7. PubMed ID: 2560213
[TBL] [Abstract][Full Text] [Related]
36. Bremazocine-induced backwards walking behavior in rats is mediated via opioid kappa receptors.
Shearman GT; Stenfors C
Pharmacol Biochem Behav; 1986 Apr; 24(4):861-3. PubMed ID: 3012599
[TBL] [Abstract][Full Text] [Related]
37. Relative effectiveness of naloxone and MR2266 in potentiating oestrogen-stimulated luteinizing hormone surges in ovariectomized female rats.
Dyer RG; Mansfield S; Dean AD
Neurosci Lett; 1984 Aug; 49(1-2):111-5. PubMed ID: 6093001
[TBL] [Abstract][Full Text] [Related]
38. Kappa-opioid diuretic effects of tifluadom, a benzodiazepine opioid agonist.
Leander JD
J Pharm Pharmacol; 1984 Aug; 36(8):555-6. PubMed ID: 6148404
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of the respiratory depressant and analgesic effects of bremazocine, a kappa-agonist.
Pazos A; Tristán C; Flórez J
Life Sci; 1983; 33 Suppl 1():579-81. PubMed ID: 6319913
[TBL] [Abstract][Full Text] [Related]
40. Kappa-opioid receptor agonists differentially affect the release of neurohypophysial hormones.
Fjalland B; Christensen JD
Pharmacol Toxicol; 1990 Mar; 66(3):176-8. PubMed ID: 2159141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
